Law & Health Weekly

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Law & Health Weekly


We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Arpida, Ltd.

Arpida reports no revenues for 2005

Arpida has made good progress during 2005. The company's initial public offering on the SWX Swiss Exchange in May raised CHF97.2 million. These new funds, in addition to existing cash resources and careful cost management, will be sufficient to allow the strategic flexibility necessary for Arpida to advance its clinical and preclinical programs and bring iclaprim to the market.

Since May 4, 2005 the Arpida share has been listed on the Main Segment of the SWX Swiss Exchange under the symbol ARPN. The company's IPO was one of the...

• View Other Issues of Law & Health Weekly
  
• View Other NewsRx Publications